TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32219557

Group type: EXPERIMENTAL
Intervention: incobotulinumtoxinA 400 U
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: incobotulinumtoxinA 250 U
Number of subjects: 100

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 100
Study: 35931132

Group type: EXPERIMENTAL
Intervention: Pentalong® 50mg (PETN) twice daily
Number of subjects: 317

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study: 33751203

Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block with 20 mL of 0.25% bupivacaine
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham block with 20 mL normal saline (Control)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block
Number of subjects: 54
Study: 34301498

Group type: EXPERIMENTAL
Intervention: Brachytherapy (EQD2 dose to 90% of High Risk CTV)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Brachytherapy (complications)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Brachytherapy (rectal dose correlation)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Brachytherapy (comparison with STIC PDR group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Brachytherapy (comparison with retroEMBRACE cohort)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Brachytherapy (training and referral)
Number of subjects: 48
Study: 32272901

Group type: EXPERIMENTAL
Intervention: UrApp-supported care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 60
Study: 34997522

Group type: EXPERIMENTAL
Intervention: Self-regulation intervention (print-based materials provided once a week for 7 weeks)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Delayed intervention group (materials provided after the second survey)
Number of subjects: 393
Study: 33259910

Group type: EXPERIMENTAL
Intervention: Kneipp arm affusions
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 30
Study: 32621729

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Autogenic Training (AT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 42
Study: 35094483

Group type: EXPERIMENTAL
Intervention: Handheld iontophoresis device
Number of subjects: 24
Study: 32040781

Group type: EXPERIMENTAL
Intervention: Focal therapy for localized prostate cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MRI-targeted biopsy (MRI-TRUS fusion image-guided biopsy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: TRUS-guided systematic biopsy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Focal therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radical treatment
Number of subjects: 0
Study: 33280460

Group type: EXPERIMENTAL
Intervention: 4-meter walk test (4mWT)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: 4-meter walk test (fastest)
Number of subjects: 162

Group type: COMPARATOR
Intervention: 6-minute walk test (6MWT)
Number of subjects: 162
Study: 32457492

Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35674485

Group type: EXPERIMENTAL
Intervention: Autonomous Sensory Meridian Response (ASMR) training for 12 weeks
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (no ASMR training)
Number of subjects: 122
Study: 34328675

Group type: EXPERIMENTAL
Intervention: Intervention designed to reduce concerns during the antenatal anomaly screening process (specific details on dosage and duration are not available).
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (specific details on the control intervention are not available).
Number of subjects: 0
Study: 32561662

Group type: EXPERIMENTAL
Intervention: EndoPredict (EPclin)
Number of subjects: 470

Group type: COMPARATOR
Intervention: Clinical Treatment Score (CTS)
Number of subjects: 470
Study: 36115574

Group type: EXPERIMENTAL
Intervention: Circuit walking, balance, cycling and strength training (CBCS) for 12 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sociocultural activities for 12 weeks
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Circuit walking, balance, cycling and strength training (CBCS)
Number of subjects: 46
Study: 34215603

Group type: EXPERIMENTAL
Intervention: More walkable school neighbourhoods
Number of subjects: 2144

Group type: EXPERIMENTAL
Intervention: Greater number of greenspaces
Number of subjects: 2144

Group type: EXPERIMENTAL
Intervention: Greater number of recreational facilities
Number of subjects: 2144

Group type: EXPERIMENTAL
Intervention: Higher cumulative PA environment score
Number of subjects: 2144

Group type: EXPERIMENTAL
Intervention: Physical activity environment measures
Number of subjects: 2144
Study: 33216782

Group type: EXPERIMENTAL
Intervention: USG-guided iSLN block (60mg of 2% lidocaine, 1.5ml each side)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: USG-guided iSLN block
Number of subjects: 100

Group type: COMPARATOR
Intervention: Inhalation with 100 mg of 2% lidocaine and 1mg of budesonide
Number of subjects: 100
Study: 32388918

Group type: EXPERIMENTAL
Intervention: Candesartan 8 mg monotherapy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg monotherapy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg monotherapy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combination of Candesartan, Amlodipine, and Atorvastatin
Number of subjects: 18
Study: 33270718

Group type: EXPERIMENTAL
Intervention: Structured ultrasound curriculum plus 20 supervised bedside thoracic ultrasounds
Number of subjects: 28

Group type: COMPARATOR
Intervention: Structured ultrasound curriculum (control)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 28
Study: 34886714

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at 100 Hz frequency and sensory threshold for 20 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with brief (30 s) electrical stimulation
Number of subjects: 0
Study: 32221079

Group type: EXPERIMENTAL
Intervention: Nomograms for cancer-specific survival (CSS)
Number of subjects: 624

Group type: EXPERIMENTAL
Intervention: Nomograms for overall survival (OS)
Number of subjects: 624
Study: 36285364

Group type: EXPERIMENTAL
Intervention: Two-stage randomized experiments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed methodology
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sample size formulas
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypothesis testing procedures
Number of subjects: 0
Study: 33085094

Group type: EXPERIMENTAL
Intervention: 10 mg of baclofen
Number of subjects: 20
Study: 34453678

Group type: EXPERIMENTAL
Intervention: COVID-19 mobility restrictions in 2020
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: PM10
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SO2 and HNO3
Number of subjects: 24
Study: 34030714

Group type: EXPERIMENTAL
Intervention: Genetically increased plasma vitamin C levels
Number of subjects: 52018
Study: 32393551

Group type: EXPERIMENTAL
Intervention: Fenofibrate treatment
Number of subjects: 0
Study: 35963941

Group type: EXPERIMENTAL
Intervention: ibrutinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: temsirolimus
Number of subjects: 0

Group type: COMPARATOR
Intervention: MCL35 gene expression proliferation assay
Number of subjects: 0

Group type: COMPARATOR
Intervention: BIRC3 mutations/deletions
Number of subjects: 0

Group type: COMPARATOR
Intervention: deletion of chromosome 8p23.3
Number of subjects: 0
Study: 34020884

Group type: EXPERIMENTAL
Intervention: Men's lacrosse protective equipment (helmet, shoulder/elbow pads, and gloves)
Number of subjects: 13
Study: 32000744

Group type: EXPERIMENTAL
Intervention: Manualized components in home visits
Number of subjects: 398

Group type: COMPARATOR
Intervention: Regular home visits (care as usual)
Number of subjects: 398
Study: 35404226

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia
Number of subjects: 80
Study: 32170365

Group type: EXPERIMENTAL
Intervention: Half-dose photodynamic therapy (PDT)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: High-density subthreshold micropulse laser (HSML)
Number of subjects: 29
Study: 35070315

Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 26

Group type: COMPARATOR
Intervention: Self-regulation-based mobile messaging
Number of subjects: 26
Study: 35073675

Group type: EXPERIMENTAL
Intervention: Greenlight laser anatomical vaporization‐incision technique (AVIT)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Photoselective vaporization of the prostate (PVP)
Number of subjects: 136
Study: 34148030

Group type: EXPERIMENTAL
Intervention: Facility-based multidomain intervention (FMI)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Home-based multidomain intervention (HMI)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control group (general health advice)
Number of subjects: 152
Study: 34225753

Group type: EXPERIMENTAL
Intervention: Biologic therapy (IL‐1 or IL‐6 inhibition)
Number of subjects: 468

Group type: COMPARATOR
Intervention: Non-biologic therapy
Number of subjects: 468
Study: 32362346

Group type: EXPERIMENTAL
Intervention: Lobeglitazone sulfate (0.5 mg) once daily for 5 days
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg) once daily for 5 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Combination of lobeglitazone sulfate (0.5 mg) and sitagliptin (100 mg) once daily for 5 days
Number of subjects: 36
Study: 35886147

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (n = 25) 3 times per week from 16 weeks of gestation until delivery
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (stretching and breathing, n = 10)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (n = 25)
Number of subjects: 35

Group type: COMPARATOR
Intervention: PUFA supplementation (not specified in detail)
Number of subjects: 35
Study: 33714724

Group type: EXPERIMENTAL
Intervention: Collaboration tools (such as frailty assessments) developed by UCOGs
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Randomized clinical trials
Number of subjects: 16

Group type: COMPARATOR
Intervention: Observational studies
Number of subjects: 16
Study: 32347778

Group type: EXPERIMENTAL
Intervention: Low-D antigen content Sabin IPV (group A)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Medium-D antigen content Sabin IPV (group B)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: High-D antigen content Sabin IPV (group C)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control Sabin IPV (group D)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control Salk IPV (group E)
Number of subjects: 600
Study: 34509259

Group type: EXPERIMENTAL
Intervention: Early orthostatic exercise by head-up tilt using the ERIGO® tilt-table for four weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Early orthostatic exercise
Number of subjects: 34
Study: 32998624

Group type: EXPERIMENTAL
Intervention: Optimal CPAP treatment
Number of subjects: 39

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 39
Study: 36142938

Group type: EXPERIMENTAL
Intervention: 1 fingertip unit (FTU) of EMLA® with microneedle patch for 30 min before cannulation
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 0.5 FTU of EMLA® with microneedle patch for 30 min
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 1 FTU of EMLA® with microneedle for 15 min
Number of subjects: 26

Group type: COMPARATOR
Intervention: 1 FTU of EMLA® with sham patch for 30 min
Number of subjects: 26
Study: 33410112

Group type: EXPERIMENTAL
Intervention: High-flow normobaric oxygen (NBO) by Venturi mask (FiO2 50%, flow 15 L/min)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: High-flow normobaric oxygen (NBO)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Routine low-flow oxygen supplementation by nasal cannula (flow 3 L/min)
Number of subjects: 91
Study: 33947319

Group type: EXPERIMENTAL
Intervention: PM training program (visual imagery training)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No‐training control group
Number of subjects: 48
Study: 34024347

Group type: EXPERIMENTAL
Intervention: Symptomatic group (bleeding)
Number of subjects: 635

Group type: COMPARATOR
Intervention: Asymptomatic group (no bleeding)
Number of subjects: 635
Study: 35342691

Group type: EXPERIMENTAL
Intervention: Mobile phone text messaging intervention (TEXT4BP), 3 times per week for 3 months
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Mobile phone text messaging intervention (TEXT4BP)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 200
Study: 35150948

Group type: EXPERIMENTAL
Intervention: High-energy high-fat diet (HE-HFD; 20.9 MJ; 65% total energy as fat)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control diet (CON; 10.9 MJ; 36% total energy as fat)
Number of subjects: 12
Study: 34159359

Group type: EXPERIMENTAL
Intervention: 25% caloric restriction (CR)
Number of subjects: 43

Group type: COMPARATOR
Intervention: ad libitum (AL) eating
Number of subjects: 43
Study: 32048203

Group type: EXPERIMENTAL
Intervention: Mask induction (group M)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Intravenous induction (group IV)
Number of subjects: 67
Study: 35726877

Group type: EXPERIMENTAL
Intervention: Non-fasting strategy (solids/fluids allowed up to 1 hour)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Fasting strategy (at least 6 hours no solids and 2 hours no fluids)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Non-fasting strategy
Number of subjects: 201

Group type: COMPARATOR
Intervention: Fasting strategy
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 201
Study: 32067393

Group type: EXPERIMENTAL
Intervention: Junior hospital dental officers (JHDOs)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Dental surgery assistants (DSAs)
Number of subjects: 18
Study: 34863052

Group type: EXPERIMENTAL
Intervention: Remote transmission (RT) system
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bedside control (BC)
Number of subjects: 80
Study: 33127414

Group type: EXPERIMENTAL
Intervention: Reewarm™ PTX DCB
Number of subjects: 200

Group type: COMPARATOR
Intervention: Plain balloon (PTA group)
Number of subjects: 200
Study: 32652973

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 217

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 217
Study: 35524202

Group type: EXPERIMENTAL
Intervention: Risk-stratified breast cancer screening strategy
Number of subjects: 85000

Group type: COMPARATOR
Intervention: Standard age-based screening
Number of subjects: 85000
Study: 33464545

Group type: EXPERIMENTAL
Intervention: ModraDoc006/r after a standardized high-fat meal
Number of subjects: 16

Group type: COMPARATOR
Intervention: ModraDoc006/r in a fasted state
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: ModraDoc006/r (both conditions)
Number of subjects: 16
Study: 32176338

Group type: EXPERIMENTAL
Intervention: Live-video demonstration (Cohort 2, N=58)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Conventional live demonstration (Cohort 1, N=58)
Number of subjects: 116
Study: 32613919

Group type: EXPERIMENTAL
Intervention: Climate Schools: Alcohol and Cannabis course (n = 3236)
Number of subjects: 6386

Group type: COMPARATOR
Intervention: Health education as usual (Control, n = 3150)
Number of subjects: 6386
Study: 35484528

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Group Therapy (CBGT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Treatment-As-Usual (TAU)
Number of subjects: 64
Study: 32844188

Group type: EXPERIMENTAL
Intervention: 1000‐kcal/d diet for 8 wk
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Weight stabilization period
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Subset of participants who gained weight between W9 and W13 (n = 33)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Subset of participants with data at all time points (n = 45)
Number of subjects: 71
Study: 35339396

Group type: EXPERIMENTAL
Intervention: Herbal formula of Foeniculum vulgare and Rosa damascena (10 g, two times a day for 4 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Polyethylene glycol 4000 (PEG 4000, two times a day for 4 weeks)
Number of subjects: 50
Study: 33704075

Group type: EXPERIMENTAL
Intervention: HealthyMoms smartphone app for 6 months
Number of subjects: 305

Group type: COMPARATOR
Intervention: Standard maternity care
Number of subjects: 305
Study: 32068572

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided recruitment manoeuvre
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional recruitment manoeuvre
Number of subjects: 86
Study: 34344340

Group type: EXPERIMENTAL
Intervention: Immediate intervention (BETTER HEALTH intervention)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Wait-list arm (control)
Number of subjects: 126
Study: 33087100

Group type: EXPERIMENTAL
Intervention: Infliximab (anti-inflammatory treatment)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 35048240

Group type: EXPERIMENTAL
Intervention: Mulberry twig alkaloids (SZ‐A)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 34439282

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program (intensity 55–65% of VO2max, duration 40 min per session)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program (intensity 75–85% of VO2max, duration 20 min per session)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Total exercise volume completed in kcal/kg/week
Number of subjects: 276
Study: 33522927

Group type: EXPERIMENTAL
Intervention: Maternal breast milk odor (MBMO)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Another mother’s breast milk odor (BMO)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control with distilled water (C)
Number of subjects: 90
Study: 35654686

Group type: EXPERIMENTAL
Intervention: 3D U-Net-based convolutional neural networks model for automatic segmentation of pharyngeal VOIs
Number of subjects: 216
Study: 32227501

Group type: EXPERIMENTAL
Intervention: 30 g/day dried Ziziphus vulgaris for 12 weeks
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 34096211

Group type: COMPARATOR
Intervention: Dietary restriction (DR) group (control) instructed not to ingest high fibre foods for 48 hours prior to PEG bowel preparation
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Non-dietary restriction (NDR) group received no dietary instruction but used PEG-based preparation
Number of subjects: 57

Group type: COMPARATOR
Intervention: Dietary restriction (DR) group
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Non-dietary restriction (NDR) group
Number of subjects: 57
Study: 34392737

Group type: EXPERIMENTAL
Intervention: Stem-first THA
Number of subjects: 114

Group type: COMPARATOR
Intervention: Cup-first THA (control group)
Number of subjects: 114
Study: 33646248

Group type: EXPERIMENTAL
Intervention: Variable Weight (VW)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Fixed Weight (FW)
Number of subjects: 42

Group type: COMPARATOR
Intervention: No Weight (NW)
Number of subjects: 42
Study: 36439107

Group type: EXPERIMENTAL
Intervention: Saline irrigation
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TA) irrigation
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no irrigation)
Number of subjects: 49
Study: 34533053

Group type: EXPERIMENTAL
Intervention: Domagrozumab
Number of subjects: 0
Study: 35799088

Group type: EXPERIMENTAL
Intervention: HMS Plus system
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional ACT-guided management
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Quintile of patients with highest average heparin concentration (≥ 4.0 mg⋅kg‐1)
Number of subjects: 100
Study: 33318814

Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery (ERAS)
Number of subjects: 32
Study: 32627205

Group type: EXPERIMENTAL
Intervention: Questionnaire 1 (included precautionary measures and messages about blood donation during the epidemic)
Number of subjects: 19491

Group type: EXPERIMENTAL
Intervention: Questionnaire 2 (did not include precautionary measures or messages)
Number of subjects: 19491

Group type: COMPARATOR
Intervention: Control group (did not receive any questionnaire)
Number of subjects: 19491
Study: 35414532

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention bundle including elements of catheter care (insertion, maintenance, and removal) implemented at three time points.
Number of subjects: 6364

Group type: COMPARATOR
Intervention: Baseline phase (no intervention).
Number of subjects: 6364

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention bundle.
Number of subjects: 6364
Study: 33769837

Group type: EXPERIMENTAL
Intervention: Community qigong classes
Number of subjects: 20

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 20
Study: 35639721

Group type: EXPERIMENTAL
Intervention: Nitrate/nitrite supplementation (beetroot juice containing 4.03 mmol nitrate, 0.29 mmol nitrite) for eight weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (nitrate/nitrite-depleted beetroot juice)
Number of subjects: 0
Study: 34965947

Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg/day
Number of subjects: 1199

Group type: COMPARATOR
Intervention: Baseline corticosteroid use (CCU)
Number of subjects: 1199
Study: 33637927

Group type: EXPERIMENTAL
Intervention: 24-month recall
Number of subjects: 2372

Group type: EXPERIMENTAL
Intervention: Risk-based recall
Number of subjects: 2372
Study: 35451408

Group type: EXPERIMENTAL
Intervention: Yanghe decoction plus NAC
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo plus NAC
Number of subjects: 128
Study: 33819910

Group type: EXPERIMENTAL
Intervention: Identity-based PSA tailored for Christians
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Identity-based PSA focused on economic values
Number of subjects: 292

Group type: COMPARATOR
Intervention: Control PSA providing only information
Number of subjects: 292
Study: 33087330

Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 242
Study: 35309831

Group type: EXPERIMENTAL
Intervention: Comprehensive nursing (group B)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 44
Study: 32598470

Group type: EXPERIMENTAL
Intervention: Generic antidepressants (sertraline, paroxetine, escitalopram, venlafaxine, mirtazapine, bupropion)
Number of subjects: 548234

Group type: COMPARATOR
Intervention: Brand-name antidepressants
Number of subjects: 548234